We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota. Organised in collaboration with the ISA Board and members of Mayo Clinic, the program promises to be both informative and engaging.

The symposium will feature a comprehensive scientific program covering various types of systemic amyloidosis, including ATTR (hereditary and wild-type), AL (light-chain), AA, and less frequent forms.

The program will delve into the basic science, pathophysiology, diagnosis, and current and emerging treatments of systemic amyloidosis. Participants will have the opportunity to learn from competitive oral and poster abstracts, gaining insights into the latest advancements in the field.

We encourage you to join Dr. Taubel and other experts in the field for what promises to be an enlightening and educational experience. 

To find out more: https://cveducation.mayo.edu/store/international-symposium-on-amyloidosis 

Latest news

Single-dose gene silencing cure for fatal heart disease comes one step closer

March 20, 2024
Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis
Read more

How Does Social Time Contribute to a Positive Workplace Culture?

March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read more

Events

ISA Symposium 2024

29-30 May 2024 
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event